NLRP4 and familial pancreatic carcinoma: Moreover, the results obtained from MTS and colony formation assays demonstrated that the knockdown of NLRP4 significantly enhanced the inhibitory effect of olaparib on the proliferation of pancreatic cancer cells (Fig. 2c–e and Extended Data Fig. 1e).